3:00 PM - 5:00 PM
[M-P4-04] Formulating and Characterizing Safe Lipidic Liquid Crystalline Nanoparticles of Atorvastatin and Oligomeric Proanthocyanidin for Atherosclerotic Disease Treatment (C000227)
Keywords:Cubosomes, hexosomes, nanoparticles, atorvastatin, oligomeric proanthocyanidin, atherosclerosis